About Us

Brent E. Boyett, DO, DMD, FASAM

Candidate for Director-at-Large

Biography and Statement

Brent E. Boyett, DO, DMD, FASAM

1. How would your election would benefit ASAM and the field of Addiction Medicine?

Dr. Boyett is known in local, national and international communities for his passion about addiction medicine and always acts as an ambassador for ASAM. As a speaker, Dr. Boyett is always educating and inviting the local physicians to be active in their state and national organizations.

He feels the stronger the organization the stronger the voice for Substance Use Disorders. He is the president of the Alabama state chapter, ALSAM. During his short time as president, he has conducted the first annual conference and was supported by many venders and had strong support from the medical community. The conference provided valuable CEU’s for the NP’s and physicians, while making enough money to hire a part-time secretary and begin creating an ALSAM website.

Dr. Boyett is heavily involved in clinical research and has given testimony to the FDA about the unmet need in our addiction communities. Through his efforts and the efforts of the team, approval was granted for a much-needed new delivery system, so physicians might better meet the needs of their patients.

Dr. Boyett serves on national and international advisory boards promoting the needs of the many untreated addiction patients. In the state of Alabama, Governor Kay Ivey, established an opioid abuse task force and Dr. Boyett was invited and began serving on the committee this year. During these committee meetings, Br. Boyett has a voice in the direction of the war on drugs. It is his mission to advocate for demand reduction as well as the supply reduction, which has been the focus of the federal government for the past decade. It is his intension to shift the dialog from criminal to chronic disease, when referring to SUD.

He believes that he can and would be a great ambassador for ASAM and the addiction community. It has been his mission and passion for the last decade. He would appreciate your consideration for Director-at-Large position.

2. What are your greatest contributions to ASAM and the field of Addiction Medicine?

Dr. Boyett is a crusader and champion for the diagnosis and treatment of substance use disorders. He makes himself available to all, educating medical professionals and civic organizations alike.

It is his desire to increase access to care and parity for SUD patients. As a researcher, Dr. Boyett has served as principle investigator in several clinical trials and has also served as a clinical advisor for the pharmaceutical industry aiding in the development of new treatment options for addictive disorders.

He is a public speaker dedicated to the effort of educating the healthcare community and the public at large on the disease model of substance used disorders and to help remove the stigma of addiction.

Dr. Boyett is a former president of The Alabama Osteopathic Medical Association and the current president of the Alabama Society of Addiction Medicine. In his role as ALSAM president, his top priorities include the effort to fully implement Parity Law and to bring addiction medicine into the mainstream of the healthcare system ultimately improving access to care for patients in need.

In 2017, Dr. Boyett was appointment by Alabama Governor Robert Bentley to serve on the Governor’s Task Force on Opioid Addiction and Abuse. This committee is made up of leaders from the state’s criminal justice system, public and mental health systems and medical profession with the assignment of combating Alabama’s opioid abuse crisis. In August Alabama Governor Kay Ivey re-confirmed this appointment.

Biographical Sketch

Dr. Brent Boyett was trained as a general dentist and is board certified in Family Medicine as a physician. He practiced both dentistry and primary care medicine until he discovered his passion in the field of addiction medicine in 2008. He became board certified in Addiction Medicine and has distinguished himself as a speaker, researcher and thought leader in the field of addiction medicine.

As a researcher, Dr. Boyett has served as principle investigator in several clinical trials and has also served as a clinical advisor for the pharmaceutical industry aiding in the development of new treatment options for addictive disorders.

He is a public speaker dedicated to the effort of educating the healthcare community and the public at large on the disease model of substance used disorders and to help remove the stigma of addiction.

Dr. Boyett is a former president of The Alabama Osteopathic Medical Association and the current president of the Alabama Society of Addiction Medicine. In his role as ALSAM president, his top priorities include the effort to fully implement Parity Law and to bring addiction medicine into the mainstream of the healthcare system ultimately improving access to care for patients in need.

In 2017, Dr. Boyett was appointment by Alabama Governor Robert Bentley to serve on the Governor’s Task Force on Opioid Addiction and Abuse. This committee is made up of leaders from the state’s criminal justice system, public and mental health systems and medical profession with the assignment of combating Alabama’s opioid abuse crisis. In August Alabama Governor Kay Ivey re-confirmed this appointment.

Recognizing the extreme unmet need for access to outpatient addiction treatment, Dr. Boyett established Pathway Partners Addiction Medicine, now known as Pathway Healthcare, an evidence based model for outpatient treatment of addictive disorders.